Alkermes’ Corporate Presentation to be Webcast at the 38th Annual Canaccord Genuity Growth Conference

DUBLIN, Aug. 1, 2018 /PRNewswire/ — Alkermes plc (Nasdaq: ALKS) announced today that its corporate presentation will be webcast live at the 38th Annual Canaccord Genuity Growth Conference on Wednesday, Aug. 8, 2018 at 10:30 a.m. ET (3:30 p.m. BST) from Boston. The presentation may be accessed under the Investors tab on and will be archived for 14 days.

Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases. The company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes’ website at

Sandra Coombs
Investor Relations
+1 781 609 6377

Alkermes plc Logo (PRNewsfoto/Alkermes plc)


Cision View original content with multimedia:

SOURCE Alkermes plc

Leave a Comment

Your email address will not be published. Required fields are marked *